A detailed history of Orion Portfolio Solutions, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 92,648 shares of FOLD stock, worth $907,023. This represents 0.01% of its overall portfolio holdings.

Number of Shares
92,648
Previous 146,788 36.88%
Holding current value
$907,023
Previous $1.46 Million 32.07%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$9.55 - $12.09 $517,037 - $654,552
-54,140 Reduced 36.88%
92,648 $989,000
Q2 2024

Aug 13, 2024

SELL
$9.04 - $11.75 $48,806 - $63,438
-5,399 Reduced 3.55%
146,788 $1.46 Million
Q1 2024

May 09, 2024

BUY
$11.43 - $14.24 $143,549 - $178,840
12,559 Added 8.99%
152,187 $1.79 Million
Q4 2023

Feb 09, 2024

SELL
$9.97 - $14.52 $146,868 - $213,894
-14,731 Reduced 9.54%
139,628 $1.98 Million
Q3 2023

Nov 01, 2023

SELL
$11.78 - $13.86 $60,749 - $71,476
-5,157 Reduced 3.23%
154,359 $1.88 Million
Q2 2023

Aug 14, 2023

SELL
$10.72 - $13.3 $58,702 - $72,830
-5,476 Reduced 3.32%
159,516 $2 Million
Q1 2023

Aug 30, 2023

BUY
$10.91 - $13.54 $59,743 - $74,145
5,476 Added 3.43%
164,992 $1.83 Million
Q1 2023

May 15, 2023

BUY
$10.91 - $13.54 $1.8 Million - $2.23 Million
164,992 New
164,992 $1.83 Million
Q3 2021

Nov 10, 2021

SELL
$8.74 - $11.84 $118,252 - $160,195
-13,530 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$8.71 - $10.72 $117,846 - $145,041
13,530 New
13,530 $130,000
Q1 2020

May 15, 2020

SELL
$6.63 - $11.16 $6,868 - $11,561
-1,036 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$7.48 - $10.75 $7,749 - $11,137
1,036 New
1,036 $10,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.